3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 1/2
2
Phase 1
2
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hodgkin Disease
1
Interventions
Radiosurgery
58
Radiotherapy
43
Magnetic Resonance Spectroscopy
39
Cyclophosphamide
34
Standard of Care
30
Surveys and Questionnaires
22
Dexamethasone
19
Educational Status
18
Therapeutics
17
Exercise
17
Radiation
16
Magnetic Resonance Imaging
16
fludarabine phosphate
15
Proton Therapy
15
Practice Guidelines as Topic
15
Methods
15
Mammography
15
Fluorodeoxyglucose F18
15
Cisplatin
15
Blood Specimen Collection
15
Acupuncture Therapy
15
Doxorubicin
14
fludarabine
13
Positron-Emission Tomography
13
Calcium Dobesilate
13
Biopsy
13
Surgical Procedures, Operative
12
Radiotherapy, Intensity-Modulated
12
Palliative Care
12
Indocyanine Green
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Has results
×
Tetanus Toxoid
×
Clear all
NCT01611298
2020-04-21
TAR
Baylor College of Medicine
Phase NA
Completed
7 enrolled
8 charts